Critics fear the U.S. is going too far to protect drug companies in trade talks, which will make it harder to fight AIDS in poor counties. Here, Paula Cannon, associate professor of molecular microbiology and immunology at the Keck School of Medicine, inspects a mouse infected with HIV for study at a medical research lab on the USC Medical School campus in Los Angeles.
Critics fear the U.S. is going too far to protect drug companies in trade talks, which will make it harder to fight AIDS in poor counties. Here, Paula Cannon, associate professor of molecular microbiology and immunology at the Keck School of Medicine, inspects a mouse infected with HIV for study at a medical research lab on the USC Medical School campus in Los Angeles. MCT
Critics fear the U.S. is going too far to protect drug companies in trade talks, which will make it harder to fight AIDS in poor counties. Here, Paula Cannon, associate professor of molecular microbiology and immunology at the Keck School of Medicine, inspects a mouse infected with HIV for study at a medical research lab on the USC Medical School campus in Los Angeles. MCT

Economy

November 13, 2013 7:49 AM

Critics say U.S. is going too far to protect drug companies in trade talks

Suggested for you

  Comments  

Videos

Editor's Choice Videos